Xiong Zhang

Title(s)	Postdoctoral Scholar, Biochemistry and Molecular Medicine
School	School of Veterinary Medicine
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer. Nat Commun. 2024 Aug 05; 15(1):6626. Xu P, Yang JC, Chen B, Ning S, Zhang X, Wang L, Nip C, Shen Y, Johnson OT, Grigorean G, Phinney B, Liu L, Wei Q, Corey E, Tepper CG, Chen HW, Evans CP, Dall'Era MA, Gao AC, Gestwicki JE, Liu C. PMID: 39103353; PMCID: PMC11300456.

View in: PubMed Mentions: Fields:
Bio Biology Sci Science
Translation:Humans Animals Cells
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. J Immunother Cancer. 2023 05; 11(5). Xu P, Yang JC, Chen B, Nip C, Van Dyke JE, Zhang X, Chen HW, Evans CP, Murphy WJ, Liu C. PMID: 37147019; PMCID: PMC10163595.

View in: PubMed Mentions: 8 Fields:
Neo Neoplasms The Therapeutics
Translation:Humans Animals
RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases. Biochem Pharmacol. 2022 02; 196:114725. Zou H, Yang N, Zhang X, Chen HW. PMID: 34384758.

View in: PubMed Mentions: 8 Fields:
Bio Biochemistry Pha Pharmacology
Translation:Humans Animals
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers (Basel). 2021 Apr 01; 13(7). Zhang X, Huang Z, Wang J, Ma Z, Yang J, Corey E, Evans CP, Yu AM, Chen HW. PMID: 33916325; PMCID: PMC8036795.

View in: PubMed Mentions: 5
A master regulator of cholesterol biosynthesis constitutes a therapeutic liability of triple negative breast cancer. Mol Cell Oncol. 2020; 7(2):1701362. Cai D, Zhang X, Chen HW. PMID: 32158915; PMCID: PMC7051132.

View in: PubMed Mentions: 6
Src Family Kinases in Brain Edema After Acute Brain Injury. Acta Neurochir Suppl. 2016; 121:185-90. Liu D, Zhang X, Hu B, Ander BP. PMID: 26463946; PMCID: PMC5100806.

View in: PubMed Mentions: 8 Fields:
Neu Neurosurgery
Translation:Humans